Cargando…

The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease

Alcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. It can cause fatty liver (steatosis), steatohepatitis, fibrosis, cirrhosis, and liver cancer. Alcohol consumption can also disturb the composition of gut microbiota, increasing the composition of harmful microbes an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Liang, Wang, Shaoxuan, Zhang, Nanhai, Zhou, Jingxuan, Mehmood, Arshad, Raka, Rifat Nowshin, Zhou, Feng, Zhao, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219895/ https://www.ncbi.nlm.nih.gov/pubmed/35740108 http://dx.doi.org/10.3390/antiox11061211

Ejemplares similares

Astragalus Polysaccharides and Saponins Alleviate Liver Injury and Regulate Gut Microbiota in Alcohol Liver Disease Mice
por: Zhou, Jingxuan, et al.
Publicado: (2021)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Folic acid ameliorates alcohol-induced liver injury via gut–liver axis homeostasis
por: Zhang, Huaqi, et al.
Publicado: (2022)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Zhu, Weifeng, et al.
Publicado: (2022)

Bioactivity of Dietary Polyphenols: The Role in LDL-C Lowering
por: Sun, Peng, et al.
Publicado: (2021)

Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis
por: Lin, Pei, et al.
Publicado: (2015)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases
por: Kwong, Eric K., et al.
Publicado: (2019)

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
por: Pezzino, Salvatore, et al.
Publicado: (2022)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

Protective Mechanism of Edible Food Plants against Alcoholic Liver Disease with Special Mention to Polyphenolic Compounds
por: Zhao, Liang, et al.
Publicado: (2021)

Protective Effects of Several Common Amino Acids, Vitamins, Organic Acids, Flavonoids and Phenolic Acids against Hepatocyte Damage Caused by Alcohol
por: Wang, Yashen, et al.
Publicado: (2022)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Study on mechanism of action of total flavonoids from Cortex Juglandis Mandshuricae against alcoholic liver disease based on “gut-liver axis”
por: Liu, Huiru, et al.
Publicado: (2023)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Gut–Liver Axis: How Do Gut Bacteria Influence the Liver?
por: Konturek, Peter Christopher, et al.
Publicado: (2018)

Potential Role of the Gut/Liver/Lung Axis in Alcohol-Induced Tissue Pathology
por: Massey, Veronica L., et al.
Publicado: (2015)

Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease
por: Carbajo-Pescador, Sara, et al.
Publicado: (2019)

The Gut–Liver Axis in Pediatric Liver Health and Disease
por: Rager, Stephanie L., et al.
Publicado: (2023)

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation
por: Cabrera, Daniel, et al.
Publicado: (2018)

Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats
por: Zhao, Hui, et al.
Publicado: (2022)

Chlorothalonil exposure induces “liver-gut axis” disorder in mice: Liver-gut axis disorder in mice
por: Tao, Huaping, et al.
Publicado: (2022)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Protective Effects of Ellagic Acid Against Alcoholic Liver Disease in Mice
por: Zhao, Liang, et al.
Publicado: (2021)

Alcohol’s Impact on the Gut and Liver
por: Pohl, Keith, et al.
Publicado: (2021)

Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
por: Fukui, Hiroshi
Publicado: (2021)

Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis
por: Li, Hang-Yu, et al.
Publicado: (2023)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

Roles of the inflammasome in the gut-liver axis
por: Wang, Junfeng, et al.
Publicado: (2019)

Effects of Pu-erh and Dian Hong tea polyphenols on the gut-liver axis in mice
por: Wang, Ning, et al.
Publicado: (2023)

Fat, cancer, the gut-liver axis and rare liver diseases
por: Berenguer, Marina
Publicado: (2020)

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
por: Das, Undurti N.
Publicado: (2018)

Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
por: Takayama, Shun, et al.
Publicado: (2021)

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
por: Chen, Xiang, et al.
Publicado: (2022)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
por: Munteanu, Camelia, et al.
Publicado: (2023)

Pingyin rose essential oil alleviates LPS-Induced inflammation in RAW 264.7 cells via the NF-κB pathway: an integrated in vitro and network pharmacology analysis
por: Raka, Rifat Nowshin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1f9upl2qka5q1ac4j2klem1v3m